… results in Medicare.
2023 Medicare reimbursement cuts
Beginning Jan. 1, 2023, allergists are facing up to a 10% reduction in Medicare reimbursement unless Congress takes legislative action to avert these cuts.
2023 Proposed MIPS Changes
For the 2023 performance year, CMS is required to weigh the cost and quality performance categories equally.
Tezspire administration remains an in-office procedure
Medicare Administrative Contractors publicly announced removal of Tezspire from their Self-Administration Drug (SAD) exclusion lists.
Drug prices lowered for Medicare beneficiaries and ACA subsidies extended
After more than a year of trying to pass the Build Back Better Act, Congress passed a slimmer version, the Inflation Reduction Act.
